The lack of GC responses in COVID-19, due to increased TNF and IL-6 expression and the rapid progress of WP disruption, result in loss of hypermutation process, which may impair the production of high-affinity antibodies in patients with severe disease (Kaneko et al., 2020; Trevelin et al., 2022). The gene discussed is IL6; the disease is COVID-19.